Assessment of treatment response by total tumor volume and global apparent diffusion coefficient using diffusion-weighted MRI in patients with metastatic bone disease: a feasibility study
about
Rapid development of image analysis research tools: Bridging the gap between researcher and clinician with pyOsiriX.Diffusion-weighted imaging outside the brain: Consensus statement from an ISMRM-sponsored workshopDiffusion MRI in early cancer therapeutic response assessment.The expanding landscape of diffusion-weighted MRI in prostate cancerIntegrated multimodal imaging of dynamic bone-tumor alterations associated with metastatic prostate cancer.Management of patients with advanced prostate cancer: recommendations of the St Gallen Advanced Prostate Cancer Consensus Conference (APCCC) 2015.Whole-Body Diffusion-Weighted Imaging in Chronic Recurrent Multifocal Osteomyelitis in ChildrenInter- and Intra-Observer Repeatability of Quantitative Whole-Body, Diffusion-Weighted Imaging (WBDWI) in Metastatic Bone DiseaseDCE-MRI, DW-MRI, and MRS in Cancer: Challenges and Advantages of Implementing Qualitative and Quantitative Multi-parametric Imaging in the Clinic.Assessing response to treatment of bone metastases from breast cancer: what should be the standard of care?Functional MRI and CT biomarkers in oncology.New Approaches to Molecular Imaging of Multiple Myeloma.Fully automatic, multiorgan segmentation in normal whole body magnetic resonance imaging (MRI), using classification forests (CFs), convolutional neural networks (CNNs), and a multi-atlas (MA) approach.Non-Mono-Exponential Analysis of Diffusion-Weighted Imaging for Treatment Monitoring in Prostate Cancer Bone Metastases.Diffusion-weighted imaging in pediatric body magnetic resonance imaging.Imaging and dosimetry for radium-223: the potential for personalized treatment.Magnetic resonance-guided focused ultrasound for the treatment of painful bone metastases: role of apparent diffusion coefficient (ADC) and dynamic contrast enhanced (DCE) MRI in the assessment of clinical outcome.Measurements of metastatic renal cell tumours as determined by diffusion weighted imaging or computed tomography are in close agreement, a pilot study.Multiparametric Magnetic Resonance Imaging of Prostate Cancer Bone Disease: Correlation With Bone Biopsy Histological and Molecular Features.UK quantitative WB-DWI technical workgroup: consensus meeting recommendations on optimisation, quality control, processing and analysis of quantitative whole-body diffusion-weighted imaging for cancer.WB MRI and oncology: recent major advances.Diffusion-weighted (DW) MRI in lung cancers: ADC test-retest repeatability.Diffusion-weighted Imaging as a Treatment Response Biomarker for Evaluating Bone Metastases in Prostate Cancer: A Pilot Study.Application value of diffusion weighted whole body imaging with background body signal suppression in monitoring the response to treatment of bone marrow involvement in lymphoma.
P2860
Q27317305-EDEE729B-B3D3-4A04-B31D-766BC6BBFB43Q28079278-02378EBF-C275-4C77-9C6F-45116F7F0E7DQ31037179-35D9F5C7-5F25-4186-8575-A7DED10DBFAFQ33762501-622AB189-3CFD-4DA6-804A-071492D97F62Q35598954-AC808182-CAF6-41B0-A150-F8685132697FQ35879087-070BD7AB-FBFC-4594-81C0-962C08F1088BQ35901572-62A7D0ED-F626-429D-82EF-D65C03F778E0Q36001776-DAB06030-C234-4D4C-B11A-9BDA59641A06Q37368258-4EBE4D71-DEF1-4140-A54D-F22683BBE909Q38282521-C45C6FDF-380C-4C5E-BB88-370CCF86EAC8Q38314429-D42DA52E-2B62-4A85-B323-CA4E568B0EE2Q38626360-39D51ADC-757D-4F5B-A5C3-D07400163B81Q38653246-C31C1FFF-ABEE-427C-8D92-F91D4F7BAFBFQ38671355-DF420615-093F-428C-A196-F99769764E03Q38845267-FAF46706-339A-4A3E-A0DE-18F6007EAE33Q39400630-8A4A8557-13BD-4C18-859C-7BDDCF559E6AQ39447376-32D68BF1-F5C8-4A7D-A52F-901F7C8C02DBQ42291319-5707725C-57E9-405D-B0A2-C368DE662CCDQ42690512-2A3EAA98-6B90-4614-9589-B8D7CC6B9CC4Q47404572-75D009C4-F1B7-4078-AC7C-E734E90FB04BQ47732077-2F85A765-55E0-48EC-856F-87554D437824Q47923488-5B746E1B-3698-423D-9EB4-11D6DDFCC9A9Q48205685-3C2A83B7-F49A-4C0A-8242-23276D9865BDQ52983083-6582EFC3-C4C0-4AE2-AE14-3852E1A96164
P2860
Assessment of treatment response by total tumor volume and global apparent diffusion coefficient using diffusion-weighted MRI in patients with metastatic bone disease: a feasibility study
description
2014 nî lūn-bûn
@nan
2014 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Assessment of treatment respon ...... e disease: a feasibility study
@ast
Assessment of treatment respon ...... e disease: a feasibility study
@en
type
label
Assessment of treatment respon ...... e disease: a feasibility study
@ast
Assessment of treatment respon ...... e disease: a feasibility study
@en
prefLabel
Assessment of treatment respon ...... e disease: a feasibility study
@ast
Assessment of treatment respon ...... e disease: a feasibility study
@en
P2093
P2860
P50
P1433
P1476
Assessment of treatment respon ...... e disease: a feasibility study
@en
P2093
Anwar R Padhani
Matthew R Orton
Nina Tunariu
P2860
P304
P356
10.1371/JOURNAL.PONE.0091779
P407
P577
2014-04-07T00:00:00Z